eli lilly sues four telehealth compounding glp-1 companies just lost a lawsuit against Willow Health over compounded versions of #mounjaro and #zepbound Telehealth Companies Sued for Selling
Description
Obesity, vol 32(6): 1163-1168
These medications significantly delay stomach emptying, which means you have a much higher risk of aspirating during sedation
Our goal is to give you all the resources you need to help you along your weight loss journey
Highlights The starting tirzepatide dosage for weight management is low (2.5 mg weekly) and is increased slowly (by 2.5 mg weekly after at least 4 weeks) because side effects are common but usually temporary and manageable
2 Effect sizes of baseline weight on weight loss amongst GLP1-RA users across studies by ancestries
